Free Trial

Precision BioSciences (DTIL) Competitors

Precision BioSciences logo
$4.88 +0.02 (+0.41%)
Closing price 09/23/2025 04:00 PM Eastern
Extended Trading
$4.84 -0.04 (-0.92%)
As of 09/23/2025 05:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DTIL vs. CRGX, GNFT, ACRS, SOPH, VOR, TRDA, TLSA, TNYA, SLS, and MDWD

Should you be buying Precision BioSciences stock or one of its competitors? The main competitors of Precision BioSciences include CARGO Therapeutics (CRGX), GENFIT (GNFT), Aclaris Therapeutics (ACRS), SOPHiA GENETICS (SOPH), Vor Biopharma (VOR), Entrada Therapeutics (TRDA), Tiziana Life Sciences (TLSA), Tenaya Therapeutics (TNYA), SELLAS Life Sciences Group (SLS), and MediWound (MDWD). These companies are all part of the "pharmaceutical products" industry.

Precision BioSciences vs. Its Competitors

CARGO Therapeutics (NASDAQ:CRGX) and Precision BioSciences (NASDAQ:DTIL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

CARGO Therapeutics has a beta of 0.3, meaning that its stock price is 70% less volatile than the S&P 500. Comparatively, Precision BioSciences has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500.

Precision BioSciences has higher revenue and earnings than CARGO Therapeutics. CARGO Therapeutics is trading at a lower price-to-earnings ratio than Precision BioSciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CARGO TherapeuticsN/AN/A-$167.50M-$4.64-0.96
Precision BioSciences$68.70M0.84$7.17M-$8.81-0.55

93.2% of CARGO Therapeutics shares are held by institutional investors. Comparatively, 38.0% of Precision BioSciences shares are held by institutional investors. 2.9% of CARGO Therapeutics shares are held by insiders. Comparatively, 4.0% of Precision BioSciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, CARGO Therapeutics had 1 more articles in the media than Precision BioSciences. MarketBeat recorded 1 mentions for CARGO Therapeutics and 0 mentions for Precision BioSciences. Precision BioSciences' average media sentiment score of 1.02 beat CARGO Therapeutics' score of 0.00 indicating that Precision BioSciences is being referred to more favorably in the news media.

Company Overall Sentiment
CARGO Therapeutics Neutral
Precision BioSciences Positive

CARGO Therapeutics presently has a consensus price target of $15.40, indicating a potential upside of 244.52%. Precision BioSciences has a consensus price target of $47.00, indicating a potential upside of 863.11%. Given Precision BioSciences' stronger consensus rating and higher probable upside, analysts clearly believe Precision BioSciences is more favorable than CARGO Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CARGO Therapeutics
1 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.86
Precision BioSciences
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

CARGO Therapeutics has a net margin of 0.00% compared to Precision BioSciences' net margin of -6,205.79%. CARGO Therapeutics' return on equity of -43.21% beat Precision BioSciences' return on equity.

Company Net Margins Return on Equity Return on Assets
CARGO TherapeuticsN/A -43.21% -37.26%
Precision BioSciences -6,205.79%-176.47%-69.05%

Summary

Precision BioSciences beats CARGO Therapeutics on 9 of the 15 factors compared between the two stocks.

Get Precision BioSciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DTIL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DTIL vs. The Competition

MetricPrecision BioSciencesMED IndustryMedical SectorNASDAQ Exchange
Market Cap$57.28M$3.16B$5.76B$10.51B
Dividend YieldN/A2.36%5.53%4.57%
P/E Ratio-0.5521.0476.4326.62
Price / Sales0.84252.12473.3192.90
Price / CashN/A46.3537.4661.85
Price / Book0.719.7813.616.45
Net Income$7.17M-$52.73M$3.29B$271.57M
7 Day Performance7.73%3.16%1.87%2.61%
1 Month Performance-1.61%4.69%4.03%7.28%
1 Year Performance-46.90%16.37%77.41%29.60%

Precision BioSciences Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DTIL
Precision BioSciences
4.3008 of 5 stars
$4.88
+0.4%
$47.00
+863.1%
-48.0%$57.28M$68.70M-0.55200Positive News
CRGX
CARGO Therapeutics
1.577 of 5 stars
$4.47
flat
$15.40
+244.5%
N/A$216.17MN/A-0.96116
GNFT
GENFIT
1.2292 of 5 stars
$4.26
+0.3%
$9.00
+111.2%
-27.0%$212.41M$67.00M0.00120News Coverage
Gap Down
ACRS
Aclaris Therapeutics
2.8651 of 5 stars
$1.84
-5.6%
$8.71
+373.6%
+57.8%$211.25M$18.72M-1.34100
SOPH
SOPHiA GENETICS
1.493 of 5 stars
$3.17
+1.6%
$8.00
+152.4%
+3.4%$210.85M$65.17M-7.20520News Coverage
Positive News
VOR
Vor Biopharma
2.5352 of 5 stars
$1.60
-8.0%
$6.07
+279.2%
+88.4%$202.69MN/A-0.97140Gap Down
TRDA
Entrada Therapeutics
1.8817 of 5 stars
$5.06
-4.2%
$25.67
+407.2%
-65.1%$200.84M$210.78M-2.84110
TLSA
Tiziana Life Sciences
0.8368 of 5 stars
$1.70
+0.6%
N/A+72.5%$197.47MN/A0.008High Trading Volume
TNYA
Tenaya Therapeutics
2.6494 of 5 stars
$1.20
flat
$6.25
+420.8%
-32.7%$195.57MN/A-1.25110Positive News
SLS
SELLAS Life Sciences Group
1.1922 of 5 stars
$1.68
-9.2%
$7.00
+316.7%
+42.9%$194.80M$1M-5.2510
MDWD
MediWound
1.5592 of 5 stars
$17.14
-3.9%
$32.25
+88.2%
+1.9%$192.81M$20.22M-6.4980News Coverage
Positive News

Related Companies and Tools


This page (NASDAQ:DTIL) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners